title: The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
abstract: BACKGROUND
  Pulmonary hypertension (PH) is a feared complication in patients with sarcoidosis.It is an important negative prognostic factor which is reflected as a priority given to these subjects for orthotopic lung transplantation. We evaluated the relationship between BNP, 6MWD test, DLCO% values and the severity of sarcoidosis-associated pulmonary hypertension.
  
  
  METHODS
  A retrospective chart review was conducted between January 2010 and January 2015 on consecutive confirmed adult subjects diagnosed with sarcoidosis. Demographics, medical comorbidities, clinical features, pulmonary function tests (PFTs), 6MWD test, transthoracic echocardiography, laboratory investigations, radiographic findings, treatment and outcome data were collected from medical records. Subjects with suspicion for PH (i.e. those with PASP ≥ 25 mmHg) were included in the study. PH severity was classified using PASP into mild (PASP 25-49 mmHg), moderate (50-69 mmHg) and severe (≥70 mmHg). We evaluated the strength of correlation between BNP, 6MWD test, DLCO% and the severity of PH. The association between variables was performed using Pearson correlation coefficient and results were considered statistically significant if P value was <0.05.
  
  
  RESULTS
  Among the 108 cases diagnosed with sarcoidosis, we identified a total of 27 patients (25%) who had an elevated PASP suggestive of PH and met the study inclusion criteria. There was a significant correlation between BNP level (r=0.804, P=0.003), 6MWD test (r=-0.865, P=0.000), DLCO% (r=-0.513, P=0.015) and the PASP in sarcoidosis patients.
  
  
  CONCLUSIONS
  Although these simple tests should not be used as screening tools for suspecting sarcoidosis-associated pulmonary hypertension, they may be of value in following its progression in subjects already diagnosed with pulmonary hypertension.
authors.affiliation: University of Miami. msm249@med.miami.edu.
authors.forename: Mehdi
authors.initials: M
authors.lastname: Mirsaeidi
authors.forename: Hesham R
authors.initials: HR
authors.lastname: Omar
authors.forename: Robert
authors.initials: R
authors.lastname: Baughman
authors.forename: Roberto
authors.initials: R
authors.lastname: Machado
authors.forename: Nadera
authors.initials: N
authors.lastname: Sweiss
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D018450:Disease Progression; D005080:Exercise Test; D017079:Exercise Tolerance; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000097:blood / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D011237:Predictive Value of Tests; D011379:Prognosis; D011653:Pulmonary Diffusing Capacity; D012189:Retrospective Studies; D017565:Sarcoidosis, Pulmonary / Q000097:blood / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D012720:Severity of Illness Index; D013997:Time Factors; D016138:Walking
chemical_list: D015415:Biomarkers; D020097:Natriuretic Peptide, Brain
keywords: Sarcoidosis, pulmonary hypertension, pulmonary function test, BNP, 6-minute walk distance test